Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otsuka
Otsuka
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Wed, 02/20/19 - 06:09 pm
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Lundbeck
Otsuka
brexpiprazole
anti-psychotic
schizophrenia
bipolar disorder
Otsuka, Click to develop digital therapeutics for MDD
Pharmaceutical Business Review
Fri, 01/4/19 - 09:09 am
Otsuka
Click Therapeutics
digital therapeutics
major depressive disorder
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Lundbeck
Otsuka
brexpiprazole-sertraline
PTSD
clinical trials
Otsuka's dose-tracking digital pill charts its first course to market with Magellan
Fierce Pharma
Wed, 09/5/18 - 07:02 pm
Otsuka
Abilify MyCite
smart pills
digital pills
bipolar disorder
schizophrenia
The Line Between Drugs and Devices Continues to Blur
Medical Devices and Diagnostics Industry
Fri, 08/31/18 - 10:54 am
Otsuka
Magellan Health
drug-device combos
devices
FDA
drug ingestion tracking
The 10 most innovative medical devices of 2018
Mass Device
Sun, 08/5/18 - 07:21 pm
devices
Abbott Labs
Boston Scientific
BrainScope
Foundation Medicine
Integra LifeSciences
Koning Corporation
Medtronic
Otsuka
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Stat
Thu, 08/2/18 - 12:36 pm
Abilify
compulsive behavior
Bristol-Myers Squibb
Otsuka
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for frontline AML
Endpoints
Tue, 07/31/18 - 10:14 am
Otsuka
SGI-110
clinical trials
AML
Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition
Xconomy
Wed, 07/11/18 - 03:12 pm
Otsuka
Visterra
M&A
Otsuka Finds Paradise in Renal Denervation Market
Medical Devices and Diagnostics Industry
Tue, 07/10/18 - 11:01 pm
Otsuka
ReCor Medical
renal denervation
devices
M&A
FDA Approves Otsuka's Jynarque as First Treatment to Kidney Decline in Rapidy Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
CP Wire
Wed, 04/25/18 - 09:37 am
Otsuka
Jynarque
autosomal dominant polycystic kidney disease
FDA Approves Otsuka's Jynarque as First Treatment to Kidney Decline in Rapidy Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Wed, 04/25/18 - 09:36 am
Otsuka
Jynarque
autosomal dominant polycystic kidney disease
The strange story of a global pharma company’s Silicon Valley winery
Stat
Mon, 04/9/18 - 09:41 am
Otsuka
Lawsuit Claims Drug Abilify Causes Compulsive Gambling
Legal Scoops
Mon, 03/19/18 - 11:37 pm
Abilify
gambling
compulsive behavior
Bristol-Myers Squibb
Otsuka
After a decade of work, Otsuka and GW part ways on Sativex
BioPharma Dive
Wed, 12/13/17 - 06:33 pm
Otsuka
GW Pharma
Sativex
cannabindoids
First 'digital drug' faces a second litmus test: improving adherence
Medical Marketing and Media
Mon, 11/27/17 - 10:15 am
digital pills
drug adherence
Otsuka
Abilify
Proteus
Abilify MyCite
[video]Is a Digital Pill the Future of Medicine?
Motley Fool
Sat, 11/18/17 - 03:39 pm
Otsuka
digital pill
Proteus
FDA Approves First Digital Pill That You (And Others) Can Track
Forbes
Tue, 11/14/17 - 07:50 am
FDA
digital pill
Abilify MyCite
Otsuka
Proteus Digital Health
Proteus, Otsuka take another run at FDA approval for Abilify-smart pill combo
Drug Delivery Business News
Wed, 05/24/17 - 10:50 am
Proteus
Otsuka
FDA
Abilify
smart pills
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »